Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Proxalutamide significantly lowered hospitalization rates in women with mild-to-moderate COVID-19.

Ixekizumab has known and some unexpected side effects.

CS12192 effectively treats alopecia areata with better safety than current options.

Pharmacists play a key role in health education and managing treatments for conditions like hair loss and smoking cessation.

Azathioprine can help with relapses and disability in NMOSD but has more side effects and needs more research.

Irish dermatologists urgently need guidelines for using JAK inhibitors in treating alopecia areata.

Acyzol could help treat conditions caused by zinc deficiency.

Alefacept does not effectively treat severe alopecia areata.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

MK-5108 is safe and shows potential against tumors, especially alone.

A man developed autoimmune symptoms after the Pfizer COVID-19 vaccine, highlighting the need for thorough vaccine safety checks.

JAK inhibitors effectively treat severe alopecia areata with manageable side effects.

Vepdegestrant may become the first FDA-approved PROTAC degrader, marking a new era in drug development.

A new method to make finasteride for hair loss treatment was developed.

Ixekizumab is safe for long-term use with low rates of major heart-related events.

Simvastatin/ezetimibe may help treat new cases of alopecia areata but not long-term cases.

Bexarotene 1% topical gel helped some patients with alopecia areata regrow hair.

The combined treatment of Finasteride and Doxazosin affects prostate tissue by reducing cell growth and altering hormone levels.

A medicine company has recalled a drug because it contained an unlisted blood pressure medication.

A man with multiple autoimmune diseases developed liver injury from azathioprine, but his liver improved after stopping the drug.

Upadacitinib significantly improved both rheumatoid arthritis and alopecia areata in a patient.

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Ozenoxacin reduces sebum production, helping manage acne.

Experts created guidelines for who in Australia can get subsidized JAK inhibitor therapy for alopecia areata.

The combination of tadalafil and finasteride improves urinary symptoms and erectile function in men with enlarged prostates.

Genetic profiling can improve androgenetic alopecia treatment by predicting drug response and minimizing side effects.